LeadInvent Pharma Inc.

A Company Developing a Breakthrough Product to Improve Post- Surgical Survival of Glioblastoma Patients

  • Stage Product In Development
  • Industry Nanotechnology
  • Location Exton, PA, USA
  • Currency USD
  • Founded May 2015
  • Employees 8
  • Incorporation Type C-corp
  • Website LeadInventPharma.com

Company Summary

LeadInvent is head quartered in USA as LeadInvent Pharma Inc. All funding would be invested into the US Company.The US Company will be the front-end company responsible for business development, fund raising, IP holding, and licensing agreements. LeadInvent in India would operate as the operational center of the US Company. Approach: Development of a Breakthrough Product to Improve Post- Surgical Survival of Glioblastoma Patients.

Team

  • Pradip Bhatnagar

  • Pradip Bhatnagar
    Retired President of Research, Daiichi Sankyo India Pharma Private Ltd.

    Ex-President Daiichi Sankyo (India). Over 30 years of drug discovery experience across Ranbaxy (India), GSK (US), Nycomed (Norway), SmithKlineBeecham (US). From 2005 to 2008 headed new drug discovery research for Ranbaxy. 2001-2005 director in the World-wide Business Development, GSK, 1984-2000 served in various capacities in the department of Medicinal Chemistry (Beckman, SK&F, SKB, SB, GSK), and became director in 2000.

  • Pankaj Sharma
    Managing Director, LeadInvent Pharma Inc.

    CEO LeadInvent Technology. Ex-scientist Supercomputing facility for Computational biology, IIT Delhi. Project leader for IIT D – HCL Tech life science vertical, IIT D – Dabur Research Foundation cancer alliance.

  • Surojit Bose
    Director, LeadInvent Pharma Inc.

    Managed operation and finance at LeadInvent Technology, India. Ex-scientist IIT Delhi, headed Supercomputer operations and strategic planning.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free